Study to Assess Adverse Events and How Oral ABBV-1162 Moves Through the Body of Healthy Adults

StatusNot Yet Recruiting
PhasePhase 1
SponsorAbbVie
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
AbbVie
349 trials monitored
See 27 trials at risk
The goal of this study is to evaluate the safety, tolerability, and pharmacokinetics of ABBV-1162 in healthy adults.
Trial Details
NCT Number NCT07832708
Lead Sponsor AbbVie
Conditions
(from sponsor)		 Healthy Volunteers
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov